Home
NVRO
NVRO News

Latest Nevro Corp. (NVRO) News on April 2, 2025

Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?

Zacks

5 days ago

Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?

Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Zacks

13 days ago

Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down

Zacks

a month ago

Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Zacks

a month ago

Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Associated Press Finance

a month ago

Nevro: Q4 Earnings Snapshot

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

PR Newswire

a month ago

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

Nevro Corp (NVRO) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

a month ago

Nevro Corp (NVRO) Q4 2024 Earnings Report Preview: What To Expect

Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com

a month ago

Globus Medical Inc (GMED) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

2 months ago

Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth

Nevro (NVRO) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

2 months ago

Nevro (NVRO) Expected to Beat Earnings Estimates: Should You Buy?

Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?

Zacks

2 months ago

Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?

Globus Medical strengthens SCS market position with $250m Nevro deal

Medical Device Network

2 months ago

Globus Medical strengthens SCS market position with $250m Nevro deal

MT Newswires

2 months ago

Jefferies Upgrades Nevro to Hold From Underperform, Adjusts Price Target to $5.85 From $4.50

Nevro (NVRO) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

2 months ago

Nevro (NVRO) Upgraded to Buy: What Does It Mean for the Stock?

Globus Medical to acquire Nevro for $5.85 per share

TipRanks

2 months ago

Globus Medical to acquire Nevro for $5.85 per share

MT Newswires

2 months ago

Piper Sandler Upgrades Nevro to Neutral From Underweight, Adjusts Price Target to $5.85 From $6

Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock?

Zacks

2 months ago

Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock?

Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio

GuruFocus.com

2 months ago

Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio

Globus to buy Nevro for $250M

MedTech Dive

2 months ago

Globus to buy Nevro for $250M

MT Newswires

2 months ago

Globus Medical to Acquire Nevro

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

GlobeNewswire

2 months ago

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Here's Why you Should Add Nevro Stock to Your Portfolio Now

Zacks

2 months ago

Here's Why you Should Add Nevro Stock to Your Portfolio Now

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

2 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand

Zacks

3 months ago

Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand

3 US Penny Stocks With Market Caps Under $200M

Simply Wall St.

3 months ago

3 US Penny Stocks With Market Caps Under $200M

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results

PR Newswire

3 months ago

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results

What Makes Nevro (NVRO) a New Buy Stock

Zacks

3 months ago

What Makes Nevro (NVRO) a New Buy Stock

Nevro price target lowered to $4.70 from $7 at Truist

TipRanks

3 months ago

Nevro price target lowered to $4.70 from $7 at Truist

MT Newswires

3 months ago

Truist Securities Adjusts Price Target on Nevro to $4.70 From $7, Keeps Hold Rating

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

3 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Zacks

4 months ago

Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Zacks.com featured highlights include Stryve Foods, Nevro, Canoo, MSA Safety and VTEX

Zacks

4 months ago

Zacks.com featured highlights include Stryve Foods, Nevro, Canoo, MSA Safety and VTEX

Bet on 5 Top-Ranked Stocks With Rising P/E

Zacks

4 months ago

Bet on 5 Top-Ranked Stocks With Rising P/E

MT Newswires

4 months ago

Wells Fargo Upgrades Nevro to Equalweight, Price Target is $5

MT Newswires

4 months ago

Morgan Stanley Downgrades Nevro to Underweight From Equalweight, Price Target is $4

US Penny Stocks To Watch In November 2024

Simply Wall St.

4 months ago

US Penny Stocks To Watch In November 2024

NVRO Stock Declines Despite Positive Study Data of Nevro1 System

Zacks

4 months ago

NVRO Stock Declines Despite Positive Study Data of Nevro1 System

Inside a $400 billion bet on the brain-computer interface revolution

Yahoo Finance

4 months ago

Inside a $400 billion bet on the brain-computer interface revolution

New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches

PR Newswire

4 months ago

New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

5 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro Stock May Gain on the CE Mark Certification for HFX iQ

Zacks

5 months ago

Nevro Stock May Gain on the CE Mark Certification for HFX iQ

Analysts Are Updating Their Nevro Corp. (NYSE:NVRO) Estimates After Its Third-Quarter Results

Simply Wall St.

5 months ago

Analysts Are Updating Their Nevro Corp. (NYSE:NVRO) Estimates After Its Third-Quarter Results

Nevro secures CE mark for AI-based spinal cord stimulation system

Medical Device Network

5 months ago

Nevro secures CE mark for AI-based spinal cord stimulation system

Nevro Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Nevro Third Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Nevro Corp Earnings Call

Nevro Stock Rises on Q3 Earnings Beat, Revenues Decrease Y/Y

Zacks

5 months ago

Nevro Stock Rises on Q3 Earnings Beat, Revenues Decrease Y/Y

MT Newswires

5 months ago

Truist Adjusts Price Target on Nevro to $7 From $5.50, Maintains Hold Rating

MT Newswires

5 months ago

Top Premarket Gainers

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally

PR Newswire

5 months ago

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally

Nevro (NVRO) Reports Q3 Loss, Tops Revenue Estimates

Zacks

5 months ago

Nevro (NVRO) Reports Q3 Loss, Tops Revenue Estimates

Associated Press Finance

5 months ago

Nevro: Q3 Earnings Snapshot

Nevro Reports Third-Quarter 2024 Financial Results

PR Newswire

5 months ago

Nevro Reports Third-Quarter 2024 Financial Results

Nevro Corp (NVRO) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

5 months ago

Nevro Corp (NVRO) Q3 2024 Earnings Report Preview: What To Expect

New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy

PR Newswire

5 months ago

New Data Demonstrates Long-Term Improvements in Pain Intensity with Nevro's High-Frequency Spinal Cord Stimulation Therapy

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

6 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024

PR Newswire

6 months ago

Nevro to Report Third-Quarter 2024 Financial Results and Host Earnings Conference Call on November 11, 2024

Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Zacks

6 months ago

Here's Why you Should Retain Nevro Stock in Your Portfolio Now

NVRO Stock May Gain on the FDA Approval of Its HFX AdaptivAI Platform

Zacks

6 months ago

NVRO Stock May Gain on the FDA Approval of Its HFX AdaptivAI Platform

Nevro obtains FDA approval for AI-based spinal cord stimulation system

Medical Device Network

6 months ago

Nevro obtains FDA approval for AI-based spinal cord stimulation system

Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation

PR Newswire

6 months ago

Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

6 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Vanguard Group Inc's Strategic Reduction in Nevro Corp Holdings

GuruFocus.com

7 months ago

Vanguard Group Inc's Strategic Reduction in Nevro Corp Holdings

Nevro to Present at Wells Fargo 2024 Healthcare Conference

PR Newswire

7 months ago

Nevro to Present at Wells Fargo 2024 Healthcare Conference

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Zacks

7 months ago

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

8 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Engaged Capital Calls Nevro Corp. (NVRO) to Focus on Improving Profitability and Stop Pursuing Acquisitions

Insider Monkey

8 months ago

Engaged Capital Calls Nevro Corp. (NVRO) to Focus on Improving Profitability and Stop Pursuing Acquisitions

Why Is Nevro Corp. (NVRO) a Good Buy According to Engaged Capital?

Insider Monkey

8 months ago

Why Is Nevro Corp. (NVRO) a Good Buy According to Engaged Capital?

MT Newswires

8 months ago

Citigroup Upgrades Nevro to Neutral From Sell

Nevro Corp. (NYSE:NVRO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.

8 months ago

Nevro Corp. (NYSE:NVRO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

MT Newswires

8 months ago

JPMorgan Downgrades Nevro to Underweight From Neutral

MT Newswires

8 months ago

Wolfe Research Upgrades Nevro to Peer Perform

MT Newswires

8 months ago

Truist Adjusts Price Target on Nevro to $5.50 From $10, Maintains Hold Rating

Nevro considers sale as competition for pain market ramps up

MedTech Dive

8 months ago

Nevro considers sale as competition for pain market ramps up

Nevro's (NVRO) Q2 Earnings Beat Estimates, Revenues Down Y/Y

Zacks

8 months ago

Nevro's (NVRO) Q2 Earnings Beat Estimates, Revenues Down Y/Y

MT Newswires

8 months ago

JMP Securities Downgrades Nevro to Market Perform From Market Outperform; Shares Plunge Pre-Bell

MT Newswires

8 months ago

Wells Fargo Downgrades Nevro to Underweight From Equalweight, Adjusts Price Target to $5.50 From $13; Shares Plummet

MT Newswires

8 months ago

JPMorgan Downgrades Nevro to Underweight From Neutral

Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates

Zacks

8 months ago

Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates

Associated Press Finance

8 months ago

Nevro: Q2 Earnings Snapshot

Nevro Reports Second-Quarter 2024 Financial Results

PR Newswire

8 months ago

Nevro Reports Second-Quarter 2024 Financial Results

MT Newswires

9 months ago

Truist Lowers Price Target on Nevro to $10 From $11, Maintains Hold Rating

MT Newswires

9 months ago

Morgan Stanley Cuts Price Target on Nevro to $9 From $14, Keeps Equalweight Rating

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

9 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Zacks

9 months ago

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024

PR Newswire

9 months ago

Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

9 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro to Present at Truist Securities MedTech Conference

PR Newswire

10 months ago

Nevro to Present at Truist Securities MedTech Conference

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

10 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

10 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

10 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

10 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

10 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

10 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

10 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

10 months ago

Enduring role of 'treasuring the past' hailed

Why Is Nevro (NVRO) Down 8.8% Since Last Earnings Report?

Zacks

10 months ago

Why Is Nevro (NVRO) Down 8.8% Since Last Earnings Report?

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Zacks

10 months ago

Here's Why You Should Retain Nevro (NVRO) Stock for Now

Here’s Why Nevro Corp. (NVRO) Shares Detracted from Performance

Insider Monkey

10 months ago

Here’s Why Nevro Corp. (NVRO) Shares Detracted from Performance

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

PR Newswire

10 months ago

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Earnings Release: Here's Why Analysts Cut Their Nevro Corp. (NYSE:NVRO) Price Target To US$15.30

Simply Wall St.

a year ago

Earnings Release: Here's Why Analysts Cut Their Nevro Corp. (NYSE:NVRO) Price Target To US$15.30

Share on Social Networks: